Are patients with psoriasis being screened for cardiovascular risk factors? A study of screening practices and awareness among primary care physicians and cardiologists

Parsi, Kory K.; Brezinski, Elizabeth A.; Lin, Ting‐Yi; Li, Chin‐Shang; Armstrong, April W.

doi:10.1016/j.jaad.2011.09.006

Cited by 59 publications

(40 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…35,36 In the United States, less than 50% of clinicians are aware of these recommendations. 37 In Europe, 27.7% and 44.2% of psoriatic patients with SAH and DLP respectively received no antihypertensive and cholesterol-lowering pharmacotherapy. 38 …”

Section: Discussionmentioning

confidence: 99%

Diagnosis and underdiagnosis of comorbidities in psoriasis patients - need for a multidisciplinary approach

Duarte¹,

Oliveira²,

Follador³

et al. 2016

An. Bras. Dermatol.

View full text Add to dashboard Cite

BACKGROUNDPsoriasis is an immune-mediated disease that manifests predominantly in the skin, although systemic involvement may also occur. Although associated comorbidities have long been recognized and despite several studies indicating psoriasis as an independent risk factor for cardiovascular events, little has been done in general medical practice regardind screening. In the United States, less than 50% of clinicians are aware of these recommendations.OBJECTIVETo identify the prevalence of these comorbidities in 296 patients followed up at a university dermatology clinic.METHODSSystematically investigated comorbidity frequencies were compared with general practitioners' registry frequencies. Clinical features correlated with comorbidities were also investigated.RESULTSHigh prevalences of systematically investigated comorbidities such as hypertension (30%) and dyslipidemia (26.5%) were documented. Conversely, data from general practitioners' records showed that 33% of dyslipidemia cases were undiagnosed and indicated possible underdiagnosis of some comorbidities. Furthermore, an association was found between: the number of comorbidities and psoriasis duration, age and high body mass index an association was found between the number of comorbidities and psoriasis duration, age, high body mass index, waist circumference or waist-to-hip ratio. (p<0.05).CONCLUSIONDisease duration, age and high body mass index, waist circumference or waist-to-hip ratio are possible criteria for choosing which patients should be screened for comorbidities. Underdiagnosis of comorbidities by general practitioners highlights the need for a multidisciplinary approach in psoriasis management.

show abstract

Section: Discussionmentioning

confidence: 99%

Diagnosis and underdiagnosis of comorbidities in psoriasis patients - need for a multidisciplinary approach

Duarte¹,

Oliveira²,

Follador³

et al. 2016

An. Bras. Dermatol.

View full text Add to dashboard Cite

show abstract

“…Elizabeth A. Brezinski (Davis, CA, USA) assessed awareness to screen psoriasis patients for cardiovascular (CV) risk factors using surveys among primary care physicians (PCP) and cardiologists randomly selected through professional society registries 6 . Approximately 43% of US physicians reported screening patients with psoriasis for hypertension, 11% for coronary artery disease, and 30% for obesity.…”

Section: Poster Presentationsmentioning

confidence: 99%

GRAPPA Trainees Symposium 2012: A Report from the GRAPPA 2012 Annual Meeting

Garg

Touma²,

Ritchlin³

2013

J Rheumatol

View full text Add to dashboard Cite

The 2012 annual meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) in Stockholm, Sweden, began with a Trainees Symposium, which included 30 dermatology and rheumatology trainees currently involved with research in psoriasis or psoriatic arthritis. The 6 oral presentations and 24 posters presented at the meeting highlight the status of current basic and clinical research performed by members and trainees of GRAPPA.

show abstract

“…33 Despite the guideline recommendations by the NPF and AJC, uncertainty exists as to whether screening guidelines are implemented in clinical practice. 37 Investigators have assessed the screening practices by PCPs and cardiologists. 37 The authors revealed that increased experience in caring for psoriasis patients appeared to be associated with greater adherence to screening guidelines.…”

Section: How To Evaluate CV Risk Factors In Psoriasis Patientsmentioning

confidence: 99%

“…37 Investigators have assessed the screening practices by PCPs and cardiologists. 37 The authors revealed that increased experience in caring for psoriasis patients appeared to be associated with greater adherence to screening guidelines. Less than half of all physicians were aware of the increased risk of major adverse cardiac outcomes in psoriasis patients, and less than half of the physicians screened psoriasis patients for CV risk factors starting at age 20.…”

Section: How To Evaluate CV Risk Factors In Psoriasis Patientsmentioning

confidence: 99%

Psoriasis and cardiovascular disease: epidemiology, mechanisms, and clinical implications

Pearson¹,

Armstrong

2012

PTT

View full text Add to dashboard Cite

Psoriasis is a systemic inflammatory disorder, which has been reported to be associated with adverse cardiovascular (CV) risks. CV comorbidities, such as diabetes, dyslipidemia, hypertension, and obesity appear to be increased in psoriasis patients compared with the general population. Psoriasis may contribute independently to adverse cardiac outcomes after accounting for traditional CV risk factors. In this article, it was aimed to summarize large population studies that examine the relationship between psoriasis and CV risk factors and major adverse cardiac outcomes, and highlight proposed mechanisms for the observed epidemiologic link. Specifically, large population-based studies with over 1000 total subjects from 1975 to September 2008 in the English literature are highlighted. The relevant search terms in the Ovid Medline database were applied. The majority of the studies presented evidence for an increased incidence of CV risk factors and an increased risk for major adverse cardiac outcomes in patients with severe psoriasis. The increased risk in severe psoriasis necessitates regular screening for other comorbidities. Current guidelines for screening CV risk factors among psoriasis patients are discussed. Also reviewed is the scarce literature in therapeutic strategies to reduce CV risk factors and major adverse cardiac outcomes in psoriasis patients. Specifically, an emerging area of research on the effects of biologic agents on CV risk factors and CV adverse outcomes in psoriasis is discussed.

show abstract

Are patients with psoriasis being screened for cardiovascular risk factors? A study of screening practices and awareness among primary care physicians and cardiologists

Cited by 59 publications

References 32 publications

Diagnosis and underdiagnosis of comorbidities in psoriasis patients - need for a multidisciplinary approach

Diagnosis and underdiagnosis of comorbidities in psoriasis patients - need for a multidisciplinary approach

GRAPPA Trainees Symposium 2012: A Report from the GRAPPA 2012 Annual Meeting

Psoriasis and cardiovascular disease: epidemiology, mechanisms, and clinical implications

Contact Info

Product

Resources

About